Debora Barton
Director/Board Member bij AROVELLA THERAPEUTICS LIMITED
Vermogen: 25 753 $ op 31-03-2024
Profiel
Debora Barton is an Independent Non-Executive Director at Arovella Therapeutics Ltd.
since 2021.
She is also a Director at the American Cancer Society, Inc. since 2018.
Previously, she served as the Senior VP, Head-Clinical & Safety at Iovance Biotherapeutics, Inc. from 2018 to 2019.
From 2019 to 2022, she held the position of Chief Medical Officer at both CTx Operations, Inc. and Carisma Therapeutics, Inc. Currently, she is the Chief Medical Officer at TScan Therapeutics, Inc. starting from 2022.
Dr. Barton obtained a doctorate degree from Pontifícia Universidade Católica de São Paulo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 263 157 ( 0.03% ) | 25 753 $ | 31-03-2024 | |
TSCAN THERAPEUTICS, INC.
-.--% | 13-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Debora Barton
| Bedrijven | Functie | Begin |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Director/Board Member | 10-08-2021 |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Director/Board Member | 01-05-2018 |
Eerdere bekende functies van Debora Barton
| Bedrijven | Functie | Einde |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 08-04-2024 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01-06-2022 |
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-06-2022 |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-11-2019 |
Opleiding van Debora Barton
| Pontifícia Universidade Católica de São Paulo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| AROVELLA THERAPEUTICS LIMITED | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Commercial Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
